Department of Oncology, Jintan Hospital Affiliated to Jiangsu University, Jintan 213200, China.
Department of Oncology, Jintan Hospital Affiliated to Jiangsu University, Jintan 213200, China.
Biochem Biophys Res Commun. 2018 Sep 5;503(2):459-466. doi: 10.1016/j.bbrc.2018.04.124. Epub 2018 Jun 30.
Accumulating evidence has suggested the crucial roles of differentially expressed miRNAs in osteosarcoma progression. MiR-139-5p was decreased in various cancers. However, the role of miR-139-5p in the development of osteosarcoma and the underlying mechanism remain to be addressed.
MiR-139-5p and DNA methyltransferase-1 (DNMT1) mRNA expressions in osteosarcoma tissues and cells were detected by qRT-PCR and western blot analysis. The effects of miR-139-5p and DNMT1 on osteosarcoma cell migration, invasion and epithelial-mesenchymal transition (EMT) were investigated through cell migration and invasion assays, and western blot analysis. The relationship between miR-139-5p and DNMT1was explored using luciferase reporter analysis and western blot. A xenograft tumor model was employed to verify the effects of miR-139-5p on osteosarcoma.
We found that miR-139-5p was strikingly decreased in osteosarcoma tissues and cell lines. MiR-139-5p over-expression suppressed osteosarcoma cell growth, migration and invasion, while loss of miR-139-5p promoted osteosarcoma cell proliferation, migration and invasion. Following, we characterized that DNMT1 was a direct target of miR-139-5p that interacted with the 3'-untranslated region of DNMT1. MiR-139-5p regulated a down-regulation in DNMT1 protein expression levels. We also found that DNMT1 expression was increased and negatively correlated with miR-139-5p expression in osteosarcoma tissues clinically. Xenograft tumor analysis suggested that miR-139-5p over-expression reduced tumor growth in osteosarcoma in vivo through decreasing DNMT1 expressions.
MiR-139-5p suppressed the osteosarcoma progression by reducing DNMT1, supplying new insight into the molecular mechanism uncovering osteosarcoma growth.
越来越多的证据表明差异表达的 microRNA 在骨肉瘤进展中起着关键作用。miR-139-5p 在各种癌症中表达降低。然而,miR-139-5p 在骨肉瘤发展中的作用及其潜在机制仍有待解决。
通过 qRT-PCR 和 Western blot 分析检测骨肉瘤组织和细胞中 miR-139-5p 和 DNA 甲基转移酶 1(DNMT1)mRNA 的表达。通过细胞迁移和侵袭实验以及 Western blot 分析研究 miR-139-5p 和 DNMT1 对骨肉瘤细胞迁移、侵袭和上皮间质转化(EMT)的影响。利用荧光素酶报告分析和 Western blot 探讨 miR-139-5p 和 DNMT1 之间的关系。采用异种移植肿瘤模型验证 miR-139-5p 对骨肉瘤的影响。
我们发现 miR-139-5p 在骨肉瘤组织和细胞系中显著降低。miR-139-5p 过表达抑制骨肉瘤细胞生长、迁移和侵袭,而 miR-139-5p 缺失则促进骨肉瘤细胞增殖、迁移和侵袭。随后,我们确定 DNMT1 是 miR-139-5p 的直接靶点,与 DNMT1 的 3'-非翻译区相互作用。miR-139-5p 调节 DNMT1 蛋白表达水平下调。我们还发现,DNMT1 在骨肉瘤组织中的表达增加,并与 miR-139-5p 的表达呈负相关。异种移植肿瘤分析表明,miR-139-5p 过表达通过降低 DNMT1 的表达,减少体内骨肉瘤的肿瘤生长。
miR-139-5p 通过降低 DNMT1 抑制骨肉瘤的进展,为揭示骨肉瘤生长的分子机制提供了新的视角。